Aligning PCPs and Patients with Alzheimer's Research Efforts: MyAlliance for Cognitive Health
协调 PCP 和患者参与阿尔茨海默病的研究工作:MyAlliance for Cognitive Health
基本信息
- 批准号:10406998
- 负责人:
- 金额:$ 137.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdvocacyAdvocateAfrican AmericanAfrican American populationAlzheimer&aposs DiseaseAlzheimer’s disease biomarkerAwardCaringChronic CareCitiesClinicalCognitiveCommunicationCommunitiesCommunity Health AidesCommunity NetworksCommunity OutreachCommunity PracticeCounselingData Management ResourcesDementiaDiagnosisEducationEducation and OutreachEducational CurriculumEnsureFamilyFutureGeneticGenetic VariationHealthInfrastructureInvestmentsKansasKnowledgeLatinoLatino PopulationLinkMarketingMedicareMinorityMissionModelingMonoclonal Antibody R24Observational StudyParticipantPatientsPersonsPopulation HeterogeneityPreventionProcessRegistriesReproducibilityResearchRisk FactorsRuralRural HealthSamplingServicesSiteSocial WorkSpeedTalentsTherapeutic StudiesTimeTrainingTrustUnderrepresented PopulationsUniversitiesWichitaWorkclinical carecohortcostdata managementdementia careethnic differenceethnic diversityfallsimprovedinformatics infrastructureinnovationnovel strategiesoperationoutreachportabilitypreventprogramsracial and ethnicracial differenceracial diversityrecruitrural arearural dwellersskillssocialsocioeconomic diversitystudy populationtooltreatment response
项目摘要
Abstract
New models for recruiting research participants are required to support current and future trials.
Recruiting adequately diverse samples of research participants is among the biggest challenges slowing
research efforts to treat and prevent Alzheimer's disease (AD). Study populations often fall short in
representing the genetic, ethnic, racial, and socioeconomic diversity necessary to generalize trial results while
the speed of recruitment into trials directly impacts the cost and time to complete studies. These issues are
only worsening as the number and size of current and planned trials have dramatically expanded.
The University of Kansas Alzheimer's Disease Center (KU ADC; P30AG035982) created MyAlliance for
Cognitive Health (MyAlliance) to accelerate participation in research and emphasize reaching under-
represented groups (URG: predominantly African Americans, Latinos, and rural residents). The Kansas City
region and the state of Kansas are increasingly diverse (>20% minority). MyAlliance is a sustainable and
reproducible strategy for engaging a diverse population through 1) a PCP Network to improve dementia care
through a financially-sustainable Chronic Care Management program, 2) a Patient Network (MyAlliance
Research Registry, derived from patients in the PCP network), and 3) a Community Network of diverse
stakeholders delivering robust outreach and education.
The sustaining value of MyAlliance is its clinical mission to improve care for all patients and families
dealing with dementia. MyAlliance will support PCPs in community practice – emphasizing practices serving a
high proportion of URG – with social work Navigators to deliver Chronic Care Management services for their
dementia patients. This clinical value is the engine to ensure consistent PCP engagement over time and
sustain the network to create a permanent recruitment infrastructure in the community.
This R24 award will result in new approaches, content, and tools that will be portable to the AD Center
network and beyond to enhance national research recruitment efforts and work to change the culture of
research recruitment in the community by linking, aligning, and engaging PCPs, patients, and community
stakeholders with research efforts.
摘要
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD).
- DOI:10.1002/trc2.12422
- 发表时间:2023-10
- 期刊:
- 影响因子:4.8
- 作者:Szabo-Reed, Amanda N;Hall, Tristyn;Vidoni, Eric D;Van Sciver, Angela;Sewell, Monica;Burns, Jeffrey M;Cullum, C Munro;Gahan, William P;Hynan, Linda S;Kerwin, Diana R;Rossetti, Heidi;Stowe, Ann M;Vongpatanasin, Wanpen;Zhu, David C;Zhang, Rong;Keller, Jeffrey N;Binder, Ellen F
- 通讯作者:Binder, Ellen F
Impact of the COVID-19 Pandemic on Latino Families With Alzheimer Disease and Related Dementias: Qualitative Interviews With Family Caregivers and Primary Care Providers.
COVID-19 大流行对患有阿尔茨海默病和相关痴呆症的拉丁裔家庭的影响:对家庭护理人员和初级保健提供者的定性访谈。
- DOI:10.2196/42211
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Perales-Puchalt,Jaime;Peltzer,Jill;Fracachan-Cabrera,Monica;Perez,GAdriana;Ramírez,Mariana;Greiner,KAllen;Burns,JeffreyMurray
- 通讯作者:Burns,JeffreyMurray
A Collaborative Approach to Dementia Inclusion in Social Work Education: The Dementia Intensive.
将痴呆症纳入社会工作教育的协作方法:痴呆症强化。
- DOI:10.1080/10437797.2022.2039820
- 发表时间:2023
- 期刊:
- 影响因子:1.3
- 作者:Niedens,Michelle;Yeager,Amy;Vidoni,EricD;Barton,Kelli;Perales-Puchalt,Jaime;Dealey,RhondaPeterson;Quinn,Dory;Gage,LAshley
- 通讯作者:Gage,LAshley
Acceptability and Preliminary Effectiveness of a Remote Dementia Educational Training Among Primary Care Providers and Health Navigators.
- DOI:10.3233/jad-220235
- 发表时间:2022
- 期刊:
- 影响因子:4
- 作者:Perales-Puchalt, Jaime;Townley, Ryan;Niedens, Michelle;Vidoni, Eric D.;Greiner, K. Allen;Zufer, Tahira;Schwasinger-Schmidt, Tiffany;McGee, Jerrihlyn L.;Arreaza, Hector;Burns, Jeffrey M.
- 通讯作者:Burns, Jeffrey M.
Patient Polypharmacy use Following a Multi-Disciplinary Dementia Care Program in a Memory Clinic: A Retrospective Cohort Study.
- DOI:10.17161/kjm.vol16.20976
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Perales-Puchalt, Jaime;Burkhardt, Crystal;Baker, Jordan;Cernik, Colin;Townley, Ryan;Niedens, Michelle;Burns, Jeffrey M;Mudaranthakam, Dinesh Pal
- 通讯作者:Mudaranthakam, Dinesh Pal
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY Murray BURNS其他文献
JEFFREY Murray BURNS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY Murray BURNS', 18)}}的其他基金
Multidisciplinary Research Training Program in Alzheimer's Disease and Related Disorders
阿尔茨海默病及相关疾病多学科研究培训计划
- 批准号:
10672283 - 财政年份:2022
- 资助金额:
$ 137.41万 - 项目类别:
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
远程监控和虚拟协作护理控制高血压以防止认知能力下降
- 批准号:
10451202 - 财政年份:2020
- 资助金额:
$ 137.41万 - 项目类别:
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
远程监控和虚拟协作护理控制高血压以防止认知能力下降
- 批准号:
10045856 - 财政年份:2020
- 资助金额:
$ 137.41万 - 项目类别:
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
远程监控和虚拟协作护理控制高血压以防止认知能力下降
- 批准号:
10468992 - 财政年份:2020
- 资助金额:
$ 137.41万 - 项目类别:
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
远程监控和虚拟协作护理控制高血压以防止认知能力下降
- 批准号:
10693852 - 财政年份:2020
- 资助金额:
$ 137.41万 - 项目类别:
Enhanced Mediterranean Diet for Alzheimer's Disease Prevention
强化地中海饮食预防阿尔茨海默病
- 批准号:
9579375 - 财政年份:2018
- 资助金额:
$ 137.41万 - 项目类别:
Enhanced Mediterranean Diet for Alzheimer's Disease Prevention
强化地中海饮食预防阿尔茨海默病
- 批准号:
10177834 - 财政年份:2018
- 资助金额:
$ 137.41万 - 项目类别:
Enhanced Mediterranean Diet for Alzheimer's Disease Prevention
强化地中海饮食预防阿尔茨海默病
- 批准号:
10403990 - 财政年份:2018
- 资助金额:
$ 137.41万 - 项目类别:
Prescribing Smart Aging: Integrating Health Systems with Community-Based Lifestyle Interventions
开出智慧老龄化处方:将卫生系统与基于社区的生活方式干预措施相结合
- 批准号:
9240378 - 财政年份:2017
- 资助金额:
$ 137.41万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 137.41万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 137.41万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 137.41万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 137.41万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 137.41万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 137.41万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 137.41万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 137.41万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 137.41万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 137.41万 - 项目类别: